Temozolomide All-Case-Registered Surveillance (Designated Drug Use Investigation)(Study P05062)
Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to confirm the safety and efficacy of temozolomide in patients
with newly diagnosed malignant glioma (concomitant with radiotherapy and then as monotherapy)
and relapsed malignant glioma (as monotherapy) when used in the daily medical practices.
Post-marketing surveys are not considered applicable clinical trials and thus the results of
this survey will not be posted at its conclusion. The results will be submitted to public
health officials as required by applicable national and international laws.